| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |